Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14

Trial Status

Completed3
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02015819Phase 1Completed
Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
PrincipalinvestigatorStart date: 2014-10-07
NCT01172964Phase 1Completed
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Adult Anaplastic AstrocytomaAdult Anaplastic OligoastrocytomaAdult Anaplastic Oligodendroglioma+9 more
Principalinvestigator
NCT01234740Phase 1Completed
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligoastrocytoma+7 more
Principalinvestigator
NCT02055196Phase 1Withdrawn
Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Wenyin Shi, MD, PhD

Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Tumors Metastatic to BrainAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+6 more
Similarity Score18%

M. Sue O'Dorisio, MD, PhD

University of Iowa

Related
4 trials

Shared therapeutic areas:

Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score16%

Antonius Miller

Cancer and Leukemia Group B

Related
3 trials

Shared therapeutic areas:

Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score16%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Anaplastic Astrocytoma+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score14%

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Related
6 trials

Shared therapeutic areas:

Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score14%

Glenn Lesser

Wake Forest University Health Sciences

Related
7 trials

Shared therapeutic areas:

Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score14%

Nadia N. Laack, M.D.

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+4 more
Similarity Score14%

Sanjiv Gambhir, MD, PhD

Stanford University

Related
3 trials

Shared therapeutic areas:

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Evanthia Galanis

North Central Cancer Treatment Group

Related
3 trials

Shared therapeutic areas:

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Adult Brain Tumor
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02015819Phase 1PrincipalInvestigator

Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas

Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
Completed
NCT01172964Phase 1PrincipalInvestigator

A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

Adult Anaplastic AstrocytomaAdult Anaplastic OligoastrocytomaAdult Anaplastic Oligodendroglioma+9 more
Completed
NCT01234740Phase 1PrincipalInvestigator

Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases

Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligoastrocytoma+7 more
Completed
NCT02055196Phase 1PrincipalInvestigator

Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
Withdrawn

All 4 trials loaded